Your browser is no longer supported. Please, upgrade your browser.
Settings
BCLI Brainstorm Cell Therapeutics Inc. daily Stock Chart
BCLI [NASD]
Brainstorm Cell Therapeutics Inc.
Index- P/E- EPS (ttm)-1.10 Insider Own1.10% Shs Outstand28.42M Perf Week17.69%
Market Cap355.59M Forward P/E- EPS next Y-0.70 Insider Trans0.00% Shs Float22.96M Perf Month43.15%
Income-26.30M PEG- EPS next Q-0.26 Inst Own12.30% Short Float13.75% Perf Quarter158.24%
Sales- P/S- EPS this Y-52.20% Inst Trans87.42% Short Ratio5.01 Perf Half Y203.46%
Book/sh0.32 P/B41.16 EPS next Y38.60% ROA-255.20% Target Price13.50 Perf Year209.88%
Cash/sh0.54 P/C24.52 EPS next 5Y- ROE726.40% 52W Range3.43 - 13.61 Perf YTD207.71%
Dividend- P/FCF- EPS past 5Y-9.40% ROI- 52W High-3.23% Beta1.13
Dividend %- Quick Ratio1.80 Sales past 5Y- Gross Margin- 52W Low283.97% ATR1.01
Employees32 Current Ratio1.80 Sales Q/Q- Oper. Margin- RSI (14)72.74 Volatility8.23% 10.10%
OptionableYes Debt/Eq0.00 EPS Q/Q-18.80% Profit Margin- Rel Volume1.20 Prev Close12.83
ShortableYes LT Debt/Eq0.00 EarningsMay 07 BMO Payout- Avg Volume630.18K Price13.17
Recom2.00 SMA2023.60% SMA5058.84% SMA200137.86% Volume753,361 Change2.65%
Dec-19-16Reiterated Maxim Group Buy $5 → $6
Dec-22-15Reiterated Maxim Group Buy $14 → $5
Jul-09-20 09:10AM  
Jul-08-20 05:31AM  
Jul-02-20 06:49AM  
Jul-01-20 08:50AM  
Jun-25-20 08:26AM  
Jun-24-20 09:06AM  
07:00AM  
Jun-23-20 05:45AM  
Jun-15-20 09:00AM  
Jun-11-20 07:28AM  
Jun-10-20 05:40AM  
Jun-09-20 06:00AM  
Jun-04-20 07:09PM  
Jun-03-20 06:00AM  
Jun-02-20 06:00AM  
May-27-20 07:25AM  
May-18-20 06:06AM  
May-08-20 05:35AM  
May-07-20 06:30AM  
01:00AM  
May-04-20 03:30AM  
Apr-29-20 06:00AM  
Apr-08-20 06:40AM  
Apr-03-20 06:59AM  
Apr-01-20 09:00AM  
Mar-31-20 04:00AM  
Mar-16-20 03:00AM  
Mar-06-20 09:25AM  
Feb-27-20 01:00AM  
Feb-20-20 05:10AM  
Feb-18-20 07:00AM  
06:00AM  
Feb-17-20 01:00AM  
Feb-11-20 06:00AM  
Feb-10-20 01:00AM  
Feb-04-20 04:45AM  
Jan-29-20 04:00AM  
Jan-21-20 09:53AM  
Jan-17-20 06:00AM  
Jan-07-20 01:00AM  
Jan-03-20 10:21AM  
Dec-19-19 05:00AM  
Dec-18-19 05:00AM  
Dec-11-19 05:00AM  
Nov-26-19 08:05AM  
Nov-25-19 06:00AM  
Nov-21-19 06:15AM  
Nov-20-19 07:00AM  
Nov-18-19 06:32AM  
Nov-14-19 08:07AM  
07:00AM  
06:00AM  
Nov-13-19 05:00AM  
Nov-12-19 01:00AM  
Nov-05-19 06:15AM  
Oct-28-19 07:45AM  
Oct-25-19 01:00AM  
Oct-24-19 08:45AM  
Oct-23-19 01:00AM  
Oct-11-19 01:00AM  
Oct-07-19 08:04AM  
Oct-02-19 06:45AM  
Sep-27-19 04:00AM  
Sep-19-19 09:19AM  
Sep-09-19 01:00AM  
Sep-06-19 01:50AM  
Aug-16-19 10:30AM  
Aug-13-19 07:30AM  
06:00AM  
Aug-05-19 01:00AM  
Jul-10-19 07:08AM  
Jul-02-19 08:15AM  
May-31-19 01:00AM  
May-30-19 01:00AM  
May-28-19 01:00AM  
May-21-19 10:15AM  
May-13-19 01:00AM  
May-10-19 05:00PM  
Apr-30-19 04:00AM  
Apr-04-19 10:30AM  
Mar-28-19 04:30AM  
Mar-26-19 06:30AM  
Mar-18-19 10:26PM  
Mar-15-19 10:50AM  
Mar-14-19 01:00AM  
Mar-13-19 11:57AM  
Mar-12-19 07:47AM  
Mar-07-19 04:00AM  
Feb-22-19 07:30AM  
Feb-21-19 06:00AM  
Feb-19-19 08:06AM  
Feb-04-19 08:22AM  
Jan-25-19 07:15AM  
Jan-22-19 08:40AM  
Jan-11-19 12:05AM  
Jan-07-19 01:30PM  
Jan-03-19 06:04AM  
Dec-27-18 07:35AM  
Dec-26-18 01:00AM  
Dec-17-18 07:34AM  
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of central nervous system (CNS) adult stem cell therapies designed to address the unmet medical needs of patients with debilitating neurodegenerative diseases. The company holds rights to develop and commercialize its NurOwn technology that utilizes a patient's own cells, which are engineered outside the body, to produce and secrete factors known to promote neuronal survival. It is developing NurOwn for various neurodegenerative diseases, including its lead indication, which is in Phase III clinical trial for the treatment of amyotrophic lateral sclerosis, as well as in Phase II for the treatment of multiple sclerosis, and preclinical trial for Parkinson's disease, Huntington's disease, and autism spectrum disorder. The company was formerly known as Golden Hand Resources Inc. and changed its name to Brainstorm Cell Therapeutics Inc. in November 2004 to reflect its new line of business in the development of novel cell therapies for neurodegenerative diseases. Brainstorm Cell Therapeutics Inc. was founded in 2000 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shah PreetamEVP, CFO and TreasurerDec 24Buy3.9611,60045,92936,600Dec 27 07:01 AM
Kern Ralph Dr.COO and Chief Medical OfficerDec 24Buy3.883,00011,640115,655Dec 27 07:01 AM
Araya ArturoChief Commercial OfficerDec 24Buy3.903,00011,7008,608Dec 27 07:00 AM
ARBEL IRITDirectorAug 28Option Exercise2.2513,33229,997169,165Aug 30 05:02 PM
ARBEL IRITDirectorAug 28Sale3.6713,33248,891155,833Aug 30 05:02 PM